COVID-19 and the RAAS-a potential role for angiotensin II?

Crit Care. 2020 Apr 7;24(1):136. doi: 10.1186/s13054-020-02862-1.

Laurence W Busse^{1

2

3}, Jonathan H Chow⁴, Michael T McCurdy⁵, Ashish K Khanna^{6

7}

¹ Department of Medicine, Emory University, Atlanta, GA, USA. lbusse@emory.edu.
² Emory Critical Care Center, Atlanta, GA, USA. lbusse@emory.edu.
³ Department of Critical Care Medicine, Emory Johns Creek Hospital, 6325 Hospital Parkway, Johns Creek, GA, 30097, USA. lbusse@emory.edu.
⁴ Department of Anesthesiology, Division of Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
⁵ Departments of Medicine and Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
⁶ Department of Anesthesiology, Section on Critical Care Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
⁷ Outcomes Research Consortium, Cleveland, OH, USA.

No abstract available

Keywords: ACE2; Angiotensin II; COVID-19; Coronavirus; RAAS.

Publication types